| Lung burden and deposition distribution of inhaled atmospheric urban ultrafine particles as the first step in their health risk assessment I Salma, P Füri, Z Németh, I Balásházy, W Hofmann, Á Farkas Atmospheric Environment 104, 39-49, 2015 | 92 | 2015 |
| Detailed mathematical description of the geometry of airway bifurcations CJ Hegedűs, I Balásházy, Á Farkas Respiratory physiology & neurobiology 141 (1), 99-114, 2004 | 85 | 2004 |
| Simulation of the effect of local obstructions and blockage on airflow and aerosol deposition in central human airways A Farkas, I Balashazy Journal of Aerosol Science 38 (8), 865-884, 2007 | 81 | 2007 |
| Characterization of regional and local deposition of inhaled aerosol drugs in the respiratory system by computational fluid and particle dynamics methods Á Farkas, I Balásházy, K Szőcs Journal of aerosol medicine 19 (3), 329-343, 2006 | 81 | 2006 |
| Quantification of particle deposition in asymmetrical tracheobronchial model geometry Á Farkas, I Balásházy Computers in Biology and Medicine 38 (4), 508-518, 2008 | 69 | 2008 |
| Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated droplets and aerosol particles BG Madas, P Füri, Á Farkas, A Nagy, A Czitrovszky, I Balásházy, ... Scientific reports 10 (1), 22430, 2020 | 59 | 2020 |
| Three-dimensional model for aerosol transport and deposition in expanding and contracting alveoli I Balásházy, W Hofmann, Á Farkas, BG Madas Inhalation toxicology 20 (6), 611-621, 2008 | 57 | 2008 |
| Significance of breath-hold time in dry powder aerosol drug therapy of COPD patients A Horváth, I Balásházy, G Tomisa, Á Farkas European Journal of Pharmaceutical Sciences 104, 145-149, 2017 | 55 | 2017 |
| Aerodynamic properties and in silico deposition of isoniazid loaded chitosan/thiolated chitosan and hyaluronic acid hybrid nanoplex DPIs as a potential TB treatment M Mukhtar, E Pallagi, I Csóka, E Benke, Á Farkas, M Zeeshan, K Burián, ... International Journal of Biological Macromolecules 165, 3007-3019, 2020 | 37 | 2020 |
| Aerodynamic properties and in silico deposition of meloxicam potassium incorporated in a carrier-free DPI pulmonary system A Chvatal, Á Farkas, I Balásházy, P Szabó-Révész, R Ambrus International Journal of Pharmaceutics 520 (1-2), 70-78, 2017 | 36 | 2017 |
| Experimental and computational study of the effect of breath-actuated mechanism built in the NEXThaler® dry powder inhaler Á Farkas, D Lewis, T Church, A Tweedie, F Mason, AE Haddrell, JP Reid, ... International Journal of Pharmaceutics 533 (1), 225-235, 2017 | 33 | 2017 |
| Non-linear relationship of cell hit and transformation probabilities in a low dose of inhaled radon progenies I Balásházy, Á Farkas, BG Madas, W Hofmann Journal of Radiological Protection 29 (2), 147, 2009 | 33 | 2009 |
| Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties R Ambrus, E Benke, Á Farkas, I Balásházy, P Szabó-Révész European Journal of Pharmaceutical Sciences 123, 20-27, 2018 | 31 | 2018 |
| Numerical simulation of emitted particle characteristics and airway deposition distribution of Symbicort® Turbuhaler® dry powder fixed combination aerosol drug Á Farkas, Á Jókay, I Balásházy, P Füri, V Müller, G Tomisa, A Horváth European Journal of pharmaceutical sciences 93, 371-379, 2016 | 31 | 2016 |
| The effect of oral and nasal breathing on the deposition of inhaled particles in upper and tracheobronchial airways F Lizal, J Elcner, J Jedelsky, M Maly, M Jicha, Á Farkas, M Belka, Z Rehak, ... Journal of Aerosol Science 150, 105649, 2020 | 28 | 2020 |
| Simulation of deposition and clearance of inhaled particles in central human airways I Balashazy, A Farkas, I Szöke, W Hofmann, R Sturm Radiation protection dosimetry 105 (1-4), 129-132, 2003 | 28 | 2003 |
| Formulation and in vitro and in silico characterization of “nano-in-micro” dry powder inhalers containing meloxicam P Party, C Bartos, Á Farkas, P Szabó-Révész, R Ambrus Pharmaceutics 13 (2), 211, 2021 | 26 | 2021 |
| In vitro and in silico (IVIS) flow characterization in an idealized human airway geometry using laser Doppler anemometry and computational fluid dynamics techniques A Kerekes, A Nagy, M Veres, I Rigó, Á Farkas, A Czitrovszky Measurement 90, 144-150, 2016 | 26 | 2016 |
| Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection Á Farkas, A Szipőcs, A Horváth, I Horváth, G Gálffy, J Varga, K Galambos, ... Respiratory Medicine 154, 133-140, 2019 | 25 | 2019 |
| Development of an innovative, carrier-based dry powder inhalation formulation containing spray-dried meloxicam potassium to improve the in vitro and in silico aerodynamic … E Benke, Á Farkas, P Szabó-Révész, R Ambrus Pharmaceutics 12 (6), 535, 2020 | 24 | 2020 |
Mona MoustafaAssistant Professor Of Physics, Faculty Of Science, Minia Univ, Minia, Egypt.在 mu.edu.eg 的电子邮件经过验证
